🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: TA-7284

Found 12 matching trials

Safety, Pharmacokinetics and Pharmacodynamics of TA-7284 in Type 2 Diabetic Patients

PHASE1

The purpose of this study is to evaluate the safety, pharmacokinetics and p...

Status

Completed

Location

P-One Clinic

Start Date

2008-06

Trial ID

NCT00707954

Treatments Being Tested

TA-7284 Placebo of TA-7284

Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus

PHASE4

The purpose of this study is to evaluate the safety and efficacy of Canagli...

Status

Completed

Location

Reserch site

Start Date

2014-08

Trial ID

NCT02227849

Treatments Being Tested

Canagliflozin (TA-7284)GLP-1 analogue

A Study to Evaluate the PK/PD and Safety of TA-7284 in Patients With Type 2 Diabetes Mellitus Who Have Moderate Renal Impairment

PHASE1

The purpose of this study is to evaluate the PK/PD and safety of TA-7284 in...

Status

Completed

Location

Reserch site

Start Date

2012-01

Trial ID

NCT01512849

Treatments Being Tested

TA-7284 Low TA-7284 High

Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)

PHASE3

The purpose of this study is to evaluate the efficacy and safety of co-admi...

Status

Completed

Location

Reserch site

Start Date

2015-01

Trial ID

NCT02354222

Treatments Being Tested

Canagliflozin Teneligliptin Placebo

An Efficacy, Safety, and Tolerability Study for TA-7284 in Patients With Type 2 Diabetes

PHASE2

The purpose of this study is to demonstrate the efficacy, safety, and toler...

Status

Completed

Location

Research site

Start Date

2009-11

Trial ID

NCT01022112

Treatments Being Tested

TA-7284-Low TA-7284-Low-middle TA-7284-High-middle TA-7284-High Placebo

Efficacy and Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

PHASE4

The purpose of this study is to evaluate the efficacy and safety of Canagli...

Status

Completed

Location

Reserch site

Start Date

2014-08

Trial ID

NCT02220920

Treatments Being Tested

Canagliflozin (TA-7284)Placebo Insulin

Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes

PHASE3

The purpose of this study is to evaluate the safety and efficacy of co-admi...

Status

Completed

Location

Research site

Start Date

2014-08

Trial ID

NCT02220907

Treatments Being Tested

Teneligliptin/Canagliflozin

Efficacy and Safety Study of TA-7284 in Patients With Type 2 Diabetes

PHASE3

The purpose of this study is to evaluate the efficacy and safety of TA-7284...

Status

Completed

Location

Reserch site

Start Date

2011-07

Trial ID

NCT01413204

Treatments Being Tested

TA-7284 Low TA-7284 High Placebo

Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus

PHASE4

This extension study was designed to evaluate the safety and efficacy of Ca...

Status

Completed

Location

Reserch site

Start Date

2014-12

Trial ID

NCT02622113

Treatments Being Tested

Canagliflozin (TA-7284)Insulin

Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)

PHASE3

The purpose of this study is to evaluate the efficacy and safety of co-admi...

Status

Completed

Location

Reserch site

Start Date

2015-01

Trial ID

NCT02354235

Treatments Being Tested

Teneligliptin Canagliflozin Placebo

Previous Next